# 21 U.S.C. 360l Postmarket surveillance

21 U.S.C. 360l Postmarket surveillance, “Postmarket surveillance”, is a U.S. Code section of [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter V—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb96-7040-b454-c8f18e0e95cb) › [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-section 21 U.S.C. 360l](https://ontology.bommaritollc.com/id/01a0f06c-cd18-7362-b421-80fe50d65937)
- `eli:cites`:
  - [21 U.S.C. 331 Prohibited acts](https://ontology.bommaritollc.com/id/01a0f06c-cc92-7163-972f-ca345be44724)
  - [21 U.S.C. 351 Adulterated drugs and devices](https://ontology.bommaritollc.com/id/01a0f06c-ccc8-7536-94e4-d8e798dad75a)
  - [21 U.S.C. 352 Misbranded drugs and devices](https://ontology.bommaritollc.com/id/01a0f06c-ccca-77a6-a36b-8f6a7374070e)
  - [21 U.S.C. 360 Registration of producers of drugs or devices](https://ontology.bommaritollc.com/id/01a0f06c-ccfb-75a5-8f8d-2899cf8ac727)
  - [21 U.S.C. 360e Premarket approval](https://ontology.bommaritollc.com/id/01a0f06c-cd07-7789-8906-93aab0532034)
  - [21 U.S.C. 360bbb-1 Dispute resolution](https://ontology.bommaritollc.com/id/01a0f06c-cd3c-718c-b848-ae6c8764bfcf)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec360l](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-3896c8b55e55)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d15c-7696-ae01-99b3b2a65202)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d2-2d74-76eb-937e-79334b132f1e)
  - [evidence from https://www.govinfo.gov/link/uscode/21/360l?type=usc&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f15-fe33-7458-bf17-f8d8b0dcdcc1)
- `schema:isPartOf`: [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d)
- `schema:legislationIdentifier`: 21 U.S.C. 360l
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code section](https://ontology.bommaritollc.com/vocab/leg/uscSection)
- `schema:name`: Postmarket surveillance
- `schema:url`: [https://www.govinfo.gov/link/uscode/21/360l?type=usc&year=mostrecent&link-type=details](https://www.govinfo.gov/link/uscode/21/360l?type=usc&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 U.S.C. 360l Postmarket surveillance

## Elsewhere

- [Official page](https://www.govinfo.gov/link/uscode/21/360l?type=usc&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec360l) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Rules made under it (36; `eli:based_on`):
  - [21 CFR Part 1000—General](https://ontology.bommaritollc.com/id/01a0f094-b8b0-7208-9147-448ff5724646)
  - [21 CFR Part 1002—Records and reports](https://ontology.bommaritollc.com/id/01a0f094-b8b1-7283-b777-845afe856952)
  - [21 CFR Part 1003—Notification of defects or failure to comply](https://ontology.bommaritollc.com/id/01a0f094-b8b2-77be-8d21-e2bcfb773481)
  - [21 CFR Part 1004—Repurchase, repairs, or replacement of electronic products](https://ontology.bommaritollc.com/id/01a0f094-b8b3-75f5-a257-81eedea31070)
  - [21 CFR Part 1010—Performance standards for electronic products: General](https://ontology.bommaritollc.com/id/01a0f094-b8b4-7598-b2bb-88e866a35d25)
  - [21 CFR Part 1020—Performance standards for ionizing radiation emitting products](https://ontology.bommaritollc.com/id/01a0f094-b8b5-7411-8bbe-acb1135618e0)
  - [21 CFR Part 1030—Performance standards for microwave and radio frequency emitting products](https://ontology.bommaritollc.com/id/01a0f094-b8b6-73c3-9325-d15eef10c256)
  - [21 CFR Part 1040—Performance standards for light-emitting products](https://ontology.bommaritollc.com/id/01a0f094-b8b7-74bf-9855-a83776254719)
  - [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)
  - [21 CFR Part 26—Mutual recognition of pharmaceutical good manufacturing practice reports, medical device quality system audit reports, and certain medical device product evaluation reports: United States and the European Community](https://ontology.bommaritollc.com/id/01a0f094-b7ef-7601-a5d1-ac01dec9bdba)
  - [21 CFR Part 310—New drugs](https://ontology.bommaritollc.com/id/01a0f094-b84b-778f-b9bc-316d7d439b85)
  - [21 CFR Part 3—Product jurisdiction](https://ontology.bommaritollc.com/id/01a0f094-b7dc-7010-b821-be4791210aae)
  - [21 CFR Part 4—Regulation of combination products](https://ontology.bommaritollc.com/id/01a0f094-b7dd-74b7-ac14-bf82566fc9ed)
  - [21 CFR Part 56—Institutional Review Boards](https://ontology.bommaritollc.com/id/01a0f094-b7f2-72a4-82d6-ac180848fce4)
  - [21 CFR Part 812—Investigational device exemptions](https://ontology.bommaritollc.com/id/01a0f094-b896-7341-a342-c3a0aea5ee4f)
  - [21 CFR Part 820 #2—Quality system regulation](https://ontology.bommaritollc.com/id/01a110fa-60b6-703e-bbcf-f0b7a4bafbc8)
  - [21 CFR Part 820—Quality system regulation](https://ontology.bommaritollc.com/id/01a0f094-b899-7260-b4bd-9d1f89923dd2)
  - [21 CFR Part 822—Postmarket surveillance](https://ontology.bommaritollc.com/id/01a0f094-b89a-7377-b3b5-7daf5931b186)
  - [21 CFR Part 861—Procedures for performance standards development](https://ontology.bommaritollc.com/id/01a0f094-b89d-7237-af12-45360563b7b5)
  - [21 CFR Part 862—Clinical chemistry and clinical toxicology devices](https://ontology.bommaritollc.com/id/01a0f094-b89e-71aa-964f-5ac371239c26)
  - [21 CFR Part 864—Hematology and pathology devices](https://ontology.bommaritollc.com/id/01a0f094-b89f-763f-be99-f78ae0fdabd2)
  - [21 CFR Part 866—Immunology and microbiology devices](https://ontology.bommaritollc.com/id/01a0f094-b8a0-767a-9436-35550d4429fc)
  - [21 CFR Part 868—Anesthesiology devices](https://ontology.bommaritollc.com/id/01a0f094-b8a1-7311-bd7e-940e922968a6)
  - [21 CFR Part 870—Cardiovascular devices](https://ontology.bommaritollc.com/id/01a0f094-b8a2-7191-9adc-3eed0d0fc3da)
  - [21 CFR Part 872—Dental devices](https://ontology.bommaritollc.com/id/01a0f094-b8a3-716f-8332-8d769fdba167)
  - [21 CFR Part 874—Ear, nose, and throat devices](https://ontology.bommaritollc.com/id/01a0f094-b8a4-7485-858b-5308e5c84a43)
  - [21 CFR Part 876—Gastroenterology-urology devices](https://ontology.bommaritollc.com/id/01a0f094-b8a5-72a4-a2e1-bd6a48fe25d1)
  - [21 CFR Part 878—General and plastic surgery devices](https://ontology.bommaritollc.com/id/01a0f094-b8a6-75de-8da5-df01a6a5a22c)
  - [21 CFR Part 880—General hospital and personal use devices](https://ontology.bommaritollc.com/id/01a0f094-b8a6-75de-8da5-df1286421a72)
  - [21 CFR Part 882—Neurological devices](https://ontology.bommaritollc.com/id/01a0f094-b8a7-7123-9bf5-ba545703b422)
  - [21 CFR Part 884—Obstetrical and gynecological devices](https://ontology.bommaritollc.com/id/01a0f094-b8a8-77cf-b28a-f91a6ab19d98)
  - [21 CFR Part 886—Ophthalmic devices](https://ontology.bommaritollc.com/id/01a0f094-b8a9-7615-92d7-8fa7f10a96b7)
  - [21 CFR Part 888—Orthopedic devices](https://ontology.bommaritollc.com/id/01a0f094-b8aa-7204-b5ab-7ecaa34e2988)
  - [21 CFR Part 890—Physical medicine devices](https://ontology.bommaritollc.com/id/01a0f094-b8ab-7002-b050-caa36598431a)
  - [21 CFR Part 892—Radiology devices](https://ontology.bommaritollc.com/id/01a0f094-b8ac-7562-b54e-c63909537c89)
  - [21 CFR Part 898—Performance standard for electrode lead wires and patient cables](https://ontology.bommaritollc.com/id/01a0f094-b8ae-7791-8163-9abf3eb953f1)
- Cited by (9; `eli:cites`):
  - [21 CFR 1000.3 Definitions.](https://ontology.bommaritollc.com/id/01a0f094-d4f2-733b-a8ec-0328d520ae67)
  - [21 CFR 820.1 Scope.](https://ontology.bommaritollc.com/id/01a0f094-ccb7-77e3-9816-690caa9d71e1)
  - [21 CFR 820.250 Statistical techniques.](https://ontology.bommaritollc.com/id/01a0f094-ccce-7210-93e1-97389827e7fb)
  - [21 U.S.C. 331 Prohibited acts](https://ontology.bommaritollc.com/id/01a0f06c-cc92-7163-972f-ca345be44724)
  - [21 U.S.C. 352 Misbranded drugs and devices](https://ontology.bommaritollc.com/id/01a0f06c-ccca-77a6-a36b-8f6a7374070e)
  - [21 U.S.C. 360e-3 Breakthrough devices](https://ontology.bommaritollc.com/id/01a0f06c-cd09-733c-a159-8c777b0481a3)
  - [21 U.S.C. 360i Records and reports on devices](https://ontology.bommaritollc.com/id/01a0f06c-cd12-7312-ba25-7c772f32c7e0)
  - [42 CFR 11.10 What definitions apply to this part?](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d)
  - [42 U.S.C. 282 Director of National Institutes of Health](https://ontology.bommaritollc.com/id/01a0f07c-da6f-7067-961a-ab05df754c84)
- Amended by (4; `eli:amends`):
  - [Pub. L. 102-300](https://ontology.bommaritollc.com/id/01a0f06c-d294-7398-abe0-444ed4f2e4f8)
  - [Pub. L. 105-115](https://ontology.bommaritollc.com/id/01a0f06c-d29f-7443-a96a-3934363a8187)
  - [Pub. L. 110-85](https://ontology.bommaritollc.com/id/01a0f06c-d2ac-7439-ab06-bdf3d920772b)
  - [Pub. L. 112-144](https://ontology.bommaritollc.com/id/01a0f06a-a3b6-70e5-8204-79bb2755f506)
- Its changes, from (1; `eli:changes`):
  - [Pub. L. 101-629](https://ontology.bommaritollc.com/id/01a0f06c-d28f-7446-932f-a99f8ce6f200)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb)
Cite as: 21 U.S.C. 360l Postmarket surveillance. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
